Delivery Order SPE2DB24D2010-SPE2DB25FAAPC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,775.34 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $32,913.38 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials, with a completion date of June 20, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,731.88 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a child delivery order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $41,578.22 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award represents a competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a ceiling value of $1,957.32. This competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under a larger contract vehicle, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a $18,687.41 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement...
- The Defense Logistics Agency awarded a $15,380.88 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.33 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price transaction with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,566.65 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $8,500.43 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials, with an ultimate completion date of April 28, 2025. This competitive contract award, issued on April 25, 2025, utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the company's corporate headquarters in...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAPCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,570.78 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills federal supply needs for military and veteran healthcare systems through open competition, demonstrating capability across diverse therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/30/25 |